Chronic infections & coronary artery disease with special reference to Chalmydia pneumoniae

S Padmavati1, U Gupta, H K Agarwal

  • 1All India Heart Foundation, New Delhi, India. padmavat@vsnl.com

Insights

This study investigated infections as a cause of coronary artery disease (CAD). No direct link was found between Chlamydia pneumoniae and CAD, though some infections may indirectly affect lipid profiles.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Biochemistry

Background:

  • Cardiovascular diseases (CVD) in India present a significant burden, with a notable percentage of cases lacking identifiable risk factors.
  • This suggests a potential, yet understudied, role for infections in the etiology of CVD.
  • Limited data exists on the association between specific infections and coronary artery disease (CAD).

Purpose of the Study:

  • To investigate the potential association between infections, specifically Chlamydia pneumoniae and other pathogens, and the development of coronary artery disease (CAD).
  • To explore the role of infectious agents in cases of acute myocardial infarction (AMI) and in patients undergoing coronary artery bypass graft (CABG) surgery.

Main Methods:

  • Patients were categorized into acute myocardial infarction (AMI), coronary artery bypass graft (CABG) surgery, and control groups.
  • Comprehensive testing included routine blood work, inflammatory markers (CRP, TLC, fibrinogen, ESR), and serological tests for antibodies (IgA, IgG) against various pathogens (C. pneumoniae, H. pylori, CMV, M. pneumoniae, Parvovirus B-19) using ELISA.
  • Chlamydia pneumoniae antigen detection via microimmunofluorescence and PCR on endothelial tissue from CABG patients, along with aortic punch biopsies, were performed.

Main Results:

  • While AMI patients showed higher associations with traditional cardiac risk factors and inflammatory markers, IgG and IgA antibody levels against C. pneumoniae did not differ significantly between AMI and control groups.
  • A significant association was observed between C. pneumoniae antigen positivity and specific lipid parameters, including HDL cholesterol, lipid tetrad index, and triglycerides.
  • Parvovirus B antigen was detected in 8.3% of tissue specimens by PCR, and 6.8% of AMI patients tested positive for parvovirus B-19 IgG antibodies.

Conclusions:

  • The study found no direct evidence implicating Chlamydia pneumoniae or other examined infective agents and viruses in the direct causation of coronary artery disease (CAD).
  • However, the findings suggest a potential indirect influence of such infections on the lipid profile, which warrants further investigation.
Abstract

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...